Literature DB >> 11505418

Clinicopathologic assessment and grading of embolized meningiomas: a correlative study of 64 patients.

A Perry1, M R Chicoine, E Filiput, J P Miller, D T Cross.   

Abstract

BACKGROUND: Preoperative embolization of meningiomas is commonly performed to minimize intraoperative bleeding, thereby facilitating surgery and reducing the necessity for transfusion. However, the resulting necrosis and compensatory proliferation reportedly have hampered subsequent histologic grading.
METHODS: The clinicopathologic features of 64 meningiomas embolized between 1989 and 1997 were assessed. Tumors were graded according to recently published criteria.
RESULTS: A good embolization result (> 75% reduction in angiographic blush) was achieved in 52%. Histologically, embolized meningiomas showed higher frequencies of necrosis (89%), nuclear atypia (72%), macronucleoli (58%), sheeting (31%), high mitotic index (30%), and brain invasion (14%) when compared with nonembolized counterparts. Median mitotic and MIB-1 indices were slightly elevated (1.5 of 10 high-power fields and 1.6%, respectively). A significant degree of necrosis (> 10%) was found in 43% and was only roughly correlated with extent of angiographic blush reduction or embolization particle size. Histologic grade was benign in 57.8%, atypical in 40.6%, and anaplastic in 1.6%. At last follow-up, there were 13 recurrences, 11 in the atypical/anaplastic (41%) versus 2 in the benign (5%) subsets (P = 0.001).
CONCLUSIONS: The authors conclude that 1) their grading scheme accurately stratifies embolized meningiomas, 2) extent of necrosis is difficult to predict using standard clinical parameters, and 3) their high incidence of atypical meningioma more likely reflects patient selection biases rather than artifacts induced by the embolization procedure. Copyright 2001 American Cancer Society.

Entities:  

Mesh:

Year:  2001        PMID: 11505418     DOI: 10.1002/1097-0142(20010801)92:3<701::aid-cncr1373>3.0.co;2-7

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  11 in total

Review 1.  Off-label use of drugs and devices in the neuroendovascular suite.

Authors:  M M Abdihalim; A E Hassan; A I Qureshi
Journal:  AJNR Am J Neuroradiol       Date:  2013-03-21       Impact factor: 3.825

2.  Post-operative cardiovascular complications and time to recurrence in meningioma patients treated with versus without pre-operative embolization: a retrospective cohort study of 741 patients.

Authors:  Hans-Georg Wirsching; Johannes Konstantin Richter; Felix Sahm; Corinne Morel; Niklaus Krayenbuehl; Elisabeth Jane Rushing; Andreas von Deimling; Antonios Valavanis; Michael Weller
Journal:  J Neurooncol       Date:  2018-09-08       Impact factor: 4.130

3.  Preoperative Embolization for Intracranial Meningiomas: Selecting Optimal Targets Based on Tumor Anatomy and Angioarchitecture.

Authors:  D Ding; D M Raper; R M Starke
Journal:  Clin Neuroradiol       Date:  2014-06-26       Impact factor: 3.649

4.  Proliferation potential of spinal meningiomas.

Authors:  Florian Roser; Makoto Nakamura; Mattia Bellinzona; Rainer Ritz; Helmut Ostertag; Marcos S Tatagiba
Journal:  Eur Spine J       Date:  2005-05-31       Impact factor: 3.134

5.  Post-embolization neurological syndrome after embolization for intracranial and skull base tumors: transient exacerbation of neurological symptoms with inflammatory responses.

Authors:  Yujiro Tanaka; Takao Hashimoto; Daisuke Watanabe; Hirofumi Okada; Daichi Kato; Shigeru Aoyagi; Jiro Akimoto; Michihiro Kohno
Journal:  Neuroradiology       Date:  2018-06-18       Impact factor: 2.804

Review 6.  Pathological classification and molecular genetics of meningiomas.

Authors:  Christian Mawrin; Arie Perry
Journal:  J Neurooncol       Date:  2010-09-01       Impact factor: 4.130

Review 7.  Necrosis score, surgical time, and transfused blood volume in patients treated with preoperative embolization of intracranial meningiomas. Analysis of a single-centre experience and a review of literature.

Authors:  A Nania; F Granata; S Vinci; A Pitrone; V Barresi; R Morabito; N Settineri; F Tomasello; C Alafaci; M Longo
Journal:  Clin Neuroradiol       Date:  2013-03-24       Impact factor: 3.649

8.  Embolized meningiomas: risk of overgrading and neo-angiogenesis.

Authors:  Valeria Barresi; Giovanni Branca; Francesca Granata; Concetta Alafaci; Maria Caffo; Giovanni Tuccari
Journal:  J Neurooncol       Date:  2013-03-18       Impact factor: 4.130

9.  Stereotactic radiosurgery as a salvage treatment option for atypical meningiomas previously submitted to surgical resection.

Authors:  Kita Sallabanda; Marcos A Dos Santos; Jose B P Salcedo; Jose A G Diaz; Felipe A Calvo; Jose Samblas; Hugo Marsiglia
Journal:  J Radiosurg SBRT       Date:  2011

Review 10.  Pathology and molecular genetics of meningioma: recent advances.

Authors:  Makoto Shibuya
Journal:  Neurol Med Chir (Tokyo)       Date:  2014-12-20       Impact factor: 1.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.